Nomura Holdings’s iShares Biotechnology ETF IBB Stock Holding History

Nomura Holdings’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-75,000	Closed	-$12.7M	–	1894
2025 Q4	$12.7M	Buy	+75,000	New	+$12.2M	0.02%	447
2024 Q2	–	Sell	-108,000	Closed	-$14.8M	–	1868
2024 Q1	$14.8M	Hold	108,000	–	–	0.04%	335
2023 Q4	$14.7M	Buy	+108,000	New	+$13.2M	0.04%	347
2020 Q4	–	Sell	-100,000	Closed	-$13.5M	–	1576
2020 Q3	$13.5M	Buy	+100,000	New	+$13.6M	0.03%	298
2019 Q2	–	Sell	-250,000	Closed	-$27.9M	–	1202
2019 Q1	$27.9M	Buy	+250,000	New	+$27.4M	0.12%	135
2017 Q1	–	Sell	-60,000	Closed	-$5.33M	–	1426
2016 Q4	$5.33M	Buy	+60,000	New	+$5.46M	0.01%	547
2016 Q2	–	Sell	-953,400	Closed	-$83M	–	1412
2016 Q1	$83M	Buy	+953,400	New	+$85.3M	0.28%	41
2015 Q2	–	Sell	-255,000	Closed	-$29.3M	–	1882
2015 Q1	$29.3M	Buy	+255,000	New	+$28.1M	0.1%	115

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nomura Holdings's IBB Position: Q2 2019 in Review

Nomura Holdings sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 127,291 shares — an estimated $14.2M sold.

Nomura Holdings first reported a position in IBB in Q2 2013 and held it in 17 quarters. The position peaked at $14.2M in Q1 2019. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

Nomura Holdings reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
Nomura Holdings sold 127,291 iShares Biotechnology ETF shares in Q2 2019, an estimated $14.2M.
Nomura Holdings first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 17 quarters.
Nomura Holdings's iShares Biotechnology ETF position peaked at $14.2M in Q1 2019.
646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Nomura Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.